Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Xvivo Perfusion AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 71,598 Less Arrow 53,852 Less Arrow 37,319
Financial expenses 3,126 More Arrow 4,171 More Arrow 5,005
Earnings before taxes 17,407 Less Arrow 8,518 Less Arrow 2,005
EBITDA 13,562 Less Arrow 5,777 Less Arrow 4,365
Total assets 209,180 Less Arrow 197,874 Less Arrow 155,737
Current assets 70,785 More Arrow 74,478 Less Arrow 42,011
Current liabilities 15,454 Less Arrow 12,120 More Arrow 12,122
Equity capital 187,766 Less Arrow 175,292 Less Arrow 128,513
- share capital 70 More Arrow 73 Less Arrow 68
Employees (average) 158 Less Arrow 130 Less Arrow 114

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 89.8% Less Arrow 88.6% Less Arrow 82.5%
Turnover per employee 453 Less Arrow 414 Less Arrow 327
Profit as a percentage of turnover 24.3% Less Arrow 15.8% Less Arrow 5.4%
Return on assets (ROA) 9.8% Less Arrow 6.4% Less Arrow 4.5%
Current ratio 458.0% More Arrow 614.5% Less Arrow 346.6%
Return on equity (ROE) 9.3% Less Arrow 4.9% Less Arrow 1.6%
Change turnover 19,577 Less Arrow 16,425 Less Arrow 14,100
Change turnover % 38% More Arrow 44% More Arrow 61%
Chg. No. of employees 28 Less Arrow 16 More Arrow 22
Chg. No. of employees % 22% Less Arrow 14% More Arrow 24%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.